Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts. - Sharmin, Sifat; Lefort, Mathilde; Andersen, Johanna Balslev; Leray, Emmanuelle; Horakova, Dana; Havrdova, Eva Kubala; Alroughani, Raed; Izquierdo, Guillermo; Ozakbas, Serkan; Patti, Francesco; Onofrj, Marco; Lugaresi, Alessandra; et al. (CNS Drugs, 2021)